The OPTION Patient
Qualified OPTION candidates must meet all of the below criteria:
- Have been diagnosed with NVAF
- Have or will have an AF ablation to treat their AF symptoms
- Have a CHADSVASC ≥ 2 (men) or ≥ 3 (women)
- Are looking for options for stroke risk reduction post-ablation
Patients do not need to have an appropriate rationale to seek a non-pharmacologic alternative to OAC to participate in this study.
Consider the following questions when identifying candidates:
- What options do you recommend for your patients for stroke risk reduction post-atrial fibrillation ablation?
- Do your patients express concern about continuing long-term OACs post-ablation?
Why This Patient Population?
- This is a large and growing population that is particularly well-suited to an alternative, like LAAC, for stroke rate reduction.
- LAAC would enable these patients to stop OAC while managing their stroke risk in a procedure with a similar safety profile to ablation.
- The recurrences of atrial fibrillation post-ablation are 3 to 7 times¹ more likely to be asymptomatic. Due to the lack of symptoms, post-ablation patients may feel better and decide to stop OAC and unknowingly increase their stroke risk.